By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NewLink Genetics 

2901 South Loop Drive
Suite 3900
Ames  Iowa  50010  U.S.A.
Phone: 515-296-5555 Fax: 515-296-5557


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
NewLink Genetics (NLNK) Announces Project To Develop New Treatment Options For The Zika Virus 2/2/2016 7:56:32 AM
NewLink Genetics (NLNK) Presents Phase Ib Data Of Indoximod In Combination With Gemcitabine/Nab-Paclitaxel For Patients With Metastatic Pancreatic Cancer That Show Encouraging Durable Responses With Delayed Pattern 1/22/2016 7:18:45 AM
NewLink Genetics (NLNK) To Present Phase 1b Data On Indoximod In Combination Therapy In Patients With Metastatic Pancreatic Cancer At ASCO GI 1/20/2016 8:03:32 AM
NewLink Genetics (NLNK) Appoints Brian Wiley As Chief Commercial Officer 1/8/2016 7:49:41 AM
NewLink Genetics (NLNK) Completes Enrollment Of Phase III PILLAR Trial Evaluating Algenpantucel-L For Patients With Locally Advanced Pancreatic Cancer 12/15/2015 7:39:43 AM
NewLink Genetics (NLNK) Presents Preliminary Safety Data From Randomized Phase II Trial Of Indoximod, An IDO Pathway Inhibitor, At San Antonio Breast Cancer Symposium 12/10/2015 7:11:23 AM
NewLink Genetics (NLNK) Reaches Enrollment Goal For Randomized Phase II Trial Of Indoximod For Patients With Metastatic Breast Cancer 12/10/2015 7:10:12 AM
NewLink Genetics (NLNK) To Present At The 27th Annual Piper Jaffray Healthcare Conference 11/30/2015 8:03:54 AM
NewLink Genetics (NLNK) Announces Clinical Data On Indoximod/Temozolomide Combination In Glioblastoma At Society For Neuro-Oncology Meeting 11/23/2015 7:25:37 AM
NewLink Genetics (NLNK) Announces Phase II Data On Indoximod At The San Antonio Breast Cancer Symposium 11/16/2015 7:40:49 AM
12345678910...
//-->